Moreover, the PTEN loss of the brain metastatic tumor cells increases the secretion of the CCL2 chemokine and the recruitment of IBA1-expressing myeloid cells that further enhance the brain metastatic process by intensifying the proliferation and reducing the apoptosis of metastatic tumor cells. The gene discussed is PTEN; the disease is neoplasm.